Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1990-10-01
1992-03-03
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514573, 514739, 514822, A61K 3119, A61K 31045, A61K 3160
Patent
active
050933256
ABSTRACT:
The invention relates to a combination preparation for thrombosis treatment consisting of acetylsalicylic acid and carbacyclin derivatives.
REFERENCES:
S. Stuerzebecher et al., "Platelet Inhibitory and Hemodynamic Effects of a New Stable PGl.sub.2 Analogue, Cicaprost (ZK 96480), in Different Animal Species and in Man," Biomed. Biochim. Acta 47 (1988), 10/11, S45-S47.
Merck Index, Tenth Edition, p. 123, Aspirin.
Prostaglandins 36(6): 751-760, 1988, Stuerzebecher & Witt, The PGI.sub.2 -analog Iloprost and the TXA.sub.2 -receptor Antagonist Sulotroban Synergistically Inhibit TXAZ-dependent Platelet Activation.
Biomed. Biochim. Acta 47(10-11): 545-547, 1989, Stuerzebecher, Hildebrand, Schoebe, Seifert & Staks, Platelet Inhibitory and Hemodynamic Effects of a New Stable DGI.sub.2 Analog, Cicaprost (ZK96480), in different animal species & man.
Baldus Berthold
Muller Bernd
Skuballa Werner
Sturzebecher Claus-Steffen
Witt Werner
Friedman S. J.
Schering Aktiengesellschaft
LandOfFree
Combination preparation having antithrombotic action does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination preparation having antithrombotic action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination preparation having antithrombotic action will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-272272